Medical Oncology and Tumor Pharmacotherapy, 0736-0118

Journal

More filtering options
  1. 2020
  2. The issues with tissues: the wide range of cell fate separation enables the evolution of multicellularity and cancer

    Emma U. Hammarlund, Amend, S. R. & Pienta, K. J., 2020, In : Medical Oncology. 37, 7, 62.

    Research output: Contribution to journalArticle

  3. 2015
  4. Expression of caspase-3 predicts prognosis in advanced noncardia gastric cancer

    Amptoulach, S., Lazaris, A. C., Giannopoulou, I., Kavantzas, N., Patsouris, E. & Tsavaris, N., 2015, In : Medical Oncology. 32, 1, p. 416

    Research output: Contribution to journalArticle

  5. Satisfactory outcome after intensive chemotherapy with pragmatic use of minimal residual disease (MRD) monitoring in older patients with Philadelphia-negative B cell precursor acute lymphoblastic leukaemia: a Swedish registry-based study

    Bergfelt, E., Kozlowski, P., Ahlberg, L., Hulegardh, E., Hagglund, H., Karlsson, K., Markuszewska-Kuczymska, A., Tomaszewska-Toporska, B., Smedmyr, B., Astrom, M., Amini, R-M. & Hallbook, H., 2015, In : Medical Oncology. 32, 4, p. 135

    Research output: Contribution to journalArticle

  6. 2014
  7. Outcome after HSCT in Philadelphia chromosome positive acute lymphoblastic leukemia in Sweden: a population-based study

    Hulegardh, E., Hagglund, H., Ahlberg, L., Karlsson, K., Karbach, H., Markuszewska, A., Persson, I., Astrom, M. & Hallbook, H., 2014, In : Medical Oncology. 31, 8, p. 66

    Research output: Contribution to journalArticle

  8. 2013
  9. High incidence of chronic graft-versus-host disease after myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukemia in Sweden: graft-versus-leukemia effect protects against relapse

    Machaczka, M., Johansson, J-E., Remberger, M., Hallböök, H., Lazarevic, V. L., Wahlin, B. E., Omar, H., Wahlin, A., Gunnar Juliusson, Kimby, E. & Hägglund, H., 2013 Dec, In : Medical Oncology. 30, 4, p. 762

    Research output: Contribution to journalArticle

  10. Deregulation of protein phosphatase expression in acute myeloid leukemia

    Kabir, N. N., Lars Rönnstrand & Julhash U. Kazi, 2013, In : Medical Oncology. 30, 2

    Research output: Contribution to journalArticle

  11. Enhanced SOX10 and KIT expression in cutaneous melanoma.

    Lars Rönnstrand & Bengt Phung, 2013, In : Medical Oncology. 30, 3, p. 648

    Research output: Contribution to journalLetter

  12. FLT3 mutations in patients with childhood acute lymphoblastic leukemia (ALL)

    Kabir, N. N., Lars Rönnstrand & Julhash U. Kazi, 2013, In : Medical Oncology. 30, 1, p. 462-462

    Research output: Contribution to journalLetter

  13. Impact of the first tumor response at eight weeks on overall survival in metastatic breast cancer patients treated with first-line combination chemotherapy

    Suzuki, C., Blomqvist, L., Hatschek, T., Carlsson, L., Einbeigi, Z., Linderholm, B., Lindh, B., Niklas Loman, Malmberg, M., Rotstein, S., Söderberg, M., Sundqvist, M., Walz, T. M., Astrom, G., Fujii, H., Jacobsson, H. & Glimelius, B., 2013, In : Medical Oncology. 30, 1, p. 415

    Research output: Contribution to journalArticle

  14. Killing of CLL and NHL cells by rituximab and ofatumumab under limited availability of complement.

    Okroj, M., Eriksson, I., Osterborg, A. & Anna Blom, 2013, In : Medical Oncology. 30, 4, p. 759

    Research output: Contribution to journalArticle

  15. Protein kinase C (PKC) as a drug target in chronic lymphocytic leukemia.

    Julhash U. Kazi, Kabir, N. N. & Lars Rönnstrand, 2013, In : Medical Oncology. 30, 4, p. 757

    Research output: Contribution to journalReview article

  16. The basic helix-loop-helix (bHLH) proteins in breast cancer progression

    Kabir, N. N., Lars Rönnstrand & Julhash U. Kazi, 2013, In : Medical Oncology. 30, 3

    Research output: Contribution to journalLetter

  17. The impact of hyperfractionated radiotherapy regimen in patients with non-small cell lung cancer

    Holgersson, G., Bergqvist, M., Nyman, J., Hoye, E., Helsing, M., Friesland, S., Holgersson, M., Ekberg, L., Morth, C., Ekman, S., Blystad, T., Ewers, S-B., Loden, B., Henriksson, R. & Bergstrom, S., 2013, In : Medical Oncology. 30, 1, p. 320

    Research output: Contribution to journalArticle

  18. 2012
  19. Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer

    Holgersson, G., Sandelin, M., Hoye, E., Bergstrom, S., Henriksson, R., Ekman, S., Nyman, J., Helsing, M., Friesland, S., Holgersson, M., Lundstrom, K. L., Janson, C., Birath, E., Morth, C., Blystad, T., Ewers, S-B., Loden, B. & Bergqvist, M., 2012, In : Medical Oncology. 29, 5, p. 3176-3182

    Research output: Contribution to journalArticle

  20. 2011
  21. Health-related quality of life after chemotherapy cycle in breast cancer in Iran

    Bastani, P. & Aliasghar Ahmad Kiadaliri, 2011, In : Medical Oncology. 28, S1, p. S70-S74

    Research output: Contribution to journalArticle

  22. 2007
  23. Erythropoietin therapy and cancer related anaemia: updated Swedish recommendations

    Ahlqvist-Rastad, J., Albertsson, M., Bergh, J., Birgegard, G., Johansson, P., Jonsson, B., Kjellén, E., Pahlman, S., Zackrisson, B. & Osterborg, A., 2007, In : Medical Oncology. 24, 3, p. 267-272

    Research output: Contribution to journalArticle

  24. Phase II studies on docetaxel alone every third week, or weekly in combination with gemcitabine in patients with primary locally advanced, metastatic, or recurrent esophageal cancer

    Albertsson, M., Johansson, B., Friesland, S., Kadar, L., Letocha, H., Frykholm, G. & Wagenius, G., 2007, In : Medical Oncology. 24, 4, p. 407-412

    Research output: Contribution to journalArticle

  25. 2006
  26. Impact of growth factors in the regulation of apoptosis in low-risk myelodysplastic syndromes.

    Tehranchi, R., 2006, In : Medical Oncology. 23, 1, p. 37-49

    Research output: Contribution to journalReview article

  27. 2001
  28. Health-related quality of life and its potential prognostic implications in patients with aggressive lymphoma: a Nordic Lymphoma Group Trial

    Mats Jerkeman, Kaasa, S., Hjermstad, M., Kvaloy, S. & Cavallin-Ståhl, E., 2001, In : Medical Oncology. 18, 1, p. 85-94

    Research output: Contribution to journalArticle

  29. 1999
  30. Hepatosplenic candidiasis after neutropenic phase of acute leukaemia

    Colović, M., LAZAREVIC, VLADIMIR., Colović, R., Janković, G., Suvajdzić, N., Bogdanović, A. & Bila, J., 1999 Jul, In : Medical Oncology. 16, 2, p. 139-42 4 p.

    Research output: Contribution to journalArticle

  31. 1997
  32. Acute megakaryoblastic leukaemia in a patient with systemic lupus erythematosus

    Colović, M., Janković, G., LAZAREVIC, VLADIMIR. & Novak, A., 1997 Mar, In : Medical Oncology. 14, 1, p. 31-4 4 p.

    Research output: Contribution to journalArticle

  33. 1996
  34. Burkitt-like blast crisis in chronic myeloid leukemia

    Colovic, M., Jankovic, G. & LAZAREVIC, VLADIMIR., 1996 Jun, In : Medical Oncology. 13, 2, p. 119-120

    Research output: Contribution to journalArticle

  35. 1990
  36. 1986